包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
生物活性 |
OTUB1/USP8-IN-1 is a potent dualOTUB1/USP8inhibitor withIC50values of 0.17 and 0.28 nM forOTUB1and USP8, respectively. OTUB1/USP8-IN-1 can be used in research ofcancer[1]. |
|||||||||||||||||||||||||||||||||||||
IC50& Target |
IC50: 0.17 nM (OTUB1) and 0.28 nM (USP8)[1] |
|||||||||||||||||||||||||||||||||||||
体外研究 (In Vitro) |
OTUB1/USP8-IN-1 (compound 61; 10 nM-10 μM; 72 h) has antiproliferative effects in KRAS-WT (H1975, EBC-1, H1703) and KRAS-mutated (H23, A549) NSCLC cell lines[1].
Cell Viability Assay[1]
Western Blot Analysis[1]
|
|||||||||||||||||||||||||||||||||||||
体内研究 (In Vivo) |
OTUB1/USP8-IN-1 (compound 61; 10 nM-10 μM; 72 h) decreases the tumor burden in the H1975 xenograft mouse model[1].
|
|||||||||||||||||||||||||||||||||||||
分子量 |
426.82 |
|||||||||||||||||||||||||||||||||||||
Formula |
C22H16ClFN2O4 |
|||||||||||||||||||||||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
|||||||||||||||||||||||||||||||||||||
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |